Abstract
Medicines based on compounds of iron, copper and zinc occupy a certain place in the pharmaceutical market. A lack of iron in the body can contribute to the development of iron deficiency anemia, and in the case of copper and zinc, a deficiency in the immune response and inflammation caused by lipid peroxidation, which ultimately leads to various joint diseases such as arthritis. The basis of the treatment and prevention of diseases is the use of chelates of salts of iron, copper and zinc, the effectiveness of which largely depends on their stability and the degree of release of trace elements in various parts of the gastrointestinal tract. Therefore, there is a need to create new long-acting drugs with a certain solubility and sufficient bioavailability. This study is devoted to the development of the optimal composition of iron, copper and zinc humate matrix tablets for oral administration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
